HOLOGIC INC Forms 3, 4 and 5: Stock Options
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 33 rows in 2011. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2011-11-10: Reporting owner MUIR GLENN P; Form 4; Security Non-qualified Stock Option (Right to Buy); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2011-11-09: Reporting owner MUIR GLENN P; Form 4; Security Non-qualified Stock Option (Right to Buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2011-11-09: Reporting owner CASCELLA ROBERT; Form 4; Security Non-qualified Stock Option (Right to Buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2011-11-09: Reporting owner Williamson Steve S; Form 4; Security Non-qualified Stock Option (Right to Buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2011-11-10 | MUIR GLENN P Director, Officer (Executive VP and CFO) | 4 | Non-qualified Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −100,000 0 owned after | $2.57 exercise price | 2011-11-14 | |
| 2011-11-09 | MUIR GLENN P Director, Officer (Executive VP and CFO) | 4 | Non-qualified Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +117,895 117,895 owned after | $17.09 exercise price | 2011-11-14 | |
| 2011-11-09 | CASCELLA ROBERT Director, Officer (CEO and President) | 4 | Non-qualified Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +402,112 402,112 owned after | $17.09 exercise price | 2011-11-14 | |
| 2011-11-09 | Williamson Steve S Officer (SVP, GYN Surgical) | 4 | Non-qualified Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +43,541 43,541 owned after | $17.09 exercise price | 2011-11-14 | |
| 2011-11-09 | STEIN JAY A Officer (Chief Technical Officer) | 4 | Non-qualified Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +35,520 35,520 owned after | $17.09 exercise price | 2011-11-14 | |
| 2011-11-09 | SOLTANI PETER Officer (SVP, Breast Health) | 4 | Non-qualified Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +43,541 43,541 owned after | $17.09 exercise price | 2011-11-14 | |
| 2011-11-09 | LAVALLEE ROBERT H Officer (SVP, Chief Accounting Officer) | 4 | Non-qualified Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +38,958 38,958 owned after | $17.09 exercise price | 2011-11-14 | |
| 2011-11-09 | Harding David Officer (SVP, International) | 4 | Non-qualified Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +43,541 43,541 owned after | $17.09 exercise price | 2011-11-14 | |
| 2011-11-09 | Casey Mark J Officer (SVP, General Counsel) | 4 | Non-qualified Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +42,968 42,968 owned after | $17.09 exercise price | 2011-11-14 | |
| 2011-11-09 | Brady David J Officer (SVP, Human Resources) | 4 | Non-qualified Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +38,958 38,958 owned after | $17.09 exercise price | 2011-11-14 | |
| 2011-11-07 | MUIR GLENN P Director, Officer (Executive VP and CFO) | 4 | Non-qualified Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −50,000 100,000 owned after | $2.57 exercise price | 2011-11-09 | |
| 2011-11-01 | Stamoulis Christiana Director | 4 | Non-qualified Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +30,967 30,967 owned after | $15.29 exercise price | 2011-11-03 | |
| 2011-10-07 | MUIR GLENN P Director, Officer (Executive VP and CFO) | 4 | Non-qualified Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −50,000 150,000 owned after | $2.57 exercise price | 2011-10-11 | |
| 2011-05-09 | Harding David Officer (SVP, International) | 4 | Non-Qualified Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −16,000 24,000 owned after | $14.50 exercise price | 2011-05-11 | |
| 2011-05-09 | Harding David Officer (SVP, International) | 4 | Non-Qualified Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −93,308 0 owned after | $16.41 exercise price | 2011-05-11 | |
| 2011-05-09 | Harding David Officer (SVP, International) | 4 | Non-Qualified Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −50,000 36,850 owned after | $18.47 exercise price | 2011-05-11 | |
| 2011-03-11 | LAVALLEE ROBERT H Officer (SVP, Chief Accounting Officer) | 4 | Non-Qualified Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −5,000 2,500 owned after | $3.56 exercise price | 2011-03-14 | |
| 2011-03-07 | LAVANCE DAVID R JR Director | 4 | Non-Qualified Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −16,071 0 owned after | $14.50 exercise price | 2011-03-09 | |
| 2011-02-15 | Williamson Steve S Officer (SVP, GYN Surgical) | 4 | Non-Qualified Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −4,400 17,600 owned after | $14.10 exercise price | 2011-02-17 | |
| 2011-02-15 | Williamson Steve S Officer (SVP, GYN Surgical) | 4 | Non-Qualified Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −12,400 18,600 owned after | $14.50 exercise price | 2011-02-17 | |
| 2011-02-09 | Casey Mark J Officer (SVP, General Counsel) | 4 | Non-Qualified Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −7,020 0 owned after | $15.81 exercise price | 2011-02-11 | |
| 2011-02-09 | Williamson Steve S Officer (SVP, GYN Surgical) | 4 | Non-Qualified Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −5,766 0 owned after | $14.25 exercise price | 2011-02-10 | |
| 2011-02-08 | WILSON WAYNE Director | 4 | Non-Qualified Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −12,302 0 owned after | $15.81 exercise price | 2011-02-09 | |
| 2011-02-03 | LEAMING NANCY Director | 4 | Non-Qualified Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −20,000 0 owned after | $3.40 exercise price | 2011-02-07 | |
| 2011-02-03 holding as of filing | Myslinski Mark D Officer (SVP, Diagnostics) | 3 | Non-Qualified Stock Option (right to buy) Derivative · Direct | Holding | $19.92 exercise price | 2011-02-03 | ||
| 2011-01-18 | CRAWFORD SALLY Director | 4 | Non-Qualified Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −24,604 0 owned after | $15.81 exercise price | 2011-01-21 | |
| 2011-01-03 | CRAWFORD SALLY Director | 4 | Non-Qualified Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −46,000 0 owned after | $13.50 exercise price | 2011-01-04 | |
| 2011-01-01 | LAVANCE DAVID R JR Director | 4 | Non-Qualified Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +12,774 12,774 owned after | $18.82 exercise price | 2011-01-04 | |
| 2011-01-01 | LEAMING NANCY Director | 4 | Non-Qualified Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +12,774 12,774 owned after | $18.82 exercise price | 2011-01-04 | |
| 2011-01-01 | Levy Lawrence M Director | 4 | Non-Qualified Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +12,774 12,774 owned after | $18.82 exercise price | 2011-01-04 | |
| 2011-01-01 | WILSON WAYNE Director | 4 | Non-Qualified Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +12,774 12,774 owned after | $18.82 exercise price | 2011-01-04 | |
| 2011-01-01 | ULLIAN ELAINE Director | 4 | Non-Qualified Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +12,774 12,774 owned after | $18.82 exercise price | 2011-01-04 | |
| 2011-01-01 | CRAWFORD SALLY Director | 4 | Non-Qualified Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +12,774 12,774 owned after | $18.82 exercise price | 2011-01-04 |